F5 insider plans sale of 515 FFIV shares

F5, Inc. (FFIV) has a Form 144 filing for the planned sale of up to 515 shares of common stock through Morgan Stanley Smith Barney LLC on or after August 3, 2026 on the NASDAQ, with an indicated aggregate market value of $33,815.88.

Rhea-AI Filing Summary

F5, Inc. (FFIV) has a Form 144 filing for the planned sale of up to 515 shares of common stock through Morgan Stanley Smith Barney LLC on or after August 3, 2026 on the NASDAQ, with an indicated aggregate market value of $33,815.88. The shares to be sold include stock acquired via Restricted Stock Units on August 1, 2025. During the prior three months, a Rule 10b5-1 plan for Angelique Okeke executed a sale of 842 common shares on May 4, 2026 for total proceeds of $271,401.86.

Key Figures

Shares planned for sale: 515 shares Planned sale aggregate value: $33,815.88 RSU-related shares: 84 shares +2 more

5 metrics

Shares planned for sale 515 shares Common stock to be sold on or after August 3, 2026

Planned sale aggregate value $33,815.88 Aggregate market value of 515 shares listed in Form 144

RSU-related shares 84 shares Shares associated with Restricted Stock Units dated August 1, 2025

Recent 10b5-1 sale shares 842 shares Common shares sold on May 4, 2026 under a 10b5-1 plan

Recent 10b5-1 sale proceeds $271,401.86 Total proceeds from 842 shares sold on May 4, 2026

Key Terms

Form 144, Rule 10b5-1, Restricted Stock Units

3 terms

Form 144 regulatory

"has a Form 144 filing for the planned sale of up to 515 shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 10b5-1 regulatory

"During the prior three months, a Rule 10b5-1 plan for Angelique Okeke"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Restricted Stock Units financial

"The shares to be sold include stock acquired via Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for FFIV in this Form 144?

The filing covers a planned sale of up to 515 shares of FFIV common stock, with an indicated aggregate market value of $33,815.88, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.

When is the FFIV insider planning to sell the 515 shares?

The Form 144 indicates the planned sale date is August 3, 2026. This is the proposed date on or after which the 515 FFIV common shares may be sold on the NASDAQ market.

How were the FFIV shares being sold originally acquired?

Part of the FFIV shares were acquired through Restricted Stock Units granted by the issuer on August 1, 2025. The Form 144 lists 84 shares associated with these RSUs, with the same date shown for acquisition and payment.

What prior FFIV stock sales are reported under the 10b5-1 plan?

The filing reports that under a Rule 10b5-1 trading plan for Angelique Okeke, 842 FFIV common shares were sold on May 4, 2026, generating total proceeds of $271,401.86 over the past three months.

Which broker is handling the planned FFIV share sale?

The planned sale of 515 FFIV common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with the shares to trade on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:38 PM Accepted by SEC EDGAR 08/03/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002060650
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	F5, INC.
SEC File Number	000-26041
Address of Issuer	801 5th Avenue Seattle WASHINGTON 98104
Phone	2062725555
Name of Person for Whose Account the Securities are To Be Sold	ANGELIQUE OKEKE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	515	33815.88	56419247	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2025	Restricted Stock Units	Issuer			84	08/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANGELIQUE OKEKE 801 5th Avenue Seattle WA 98104	Common	05/04/2026	842	271401.86

144: Remarks and Signature

Remarks
Date of Notice	08/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Angelique Okeke
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)